Redox regulation of protein kinases

Critical Reviews in Biochemistry and Molecular Biology

Volumn 48, Issue 4, 2013, Pages 332-356

  Truong, Thu H ^a   Carroll, Kate S ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cysteine; Growth factor signaling; Hydrogen peroxide; NADPH oxidase; Protein kinases; Protein oxidation; Redox regulation

Indexed keywords

CAVEOLIN 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN RECEPTOR KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; PROTEIN KINASE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ALKYLATION; APOPTOSIS; AUTOPHOSPHORYLATION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DIMERIZATION; DISULFIDE BOND; DNA SYNTHESIS; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; GOLGI COMPLEX; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIGAND BINDING; LIPID METABOLISM; MITOCHONDRION; NITROSYLATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOPHILICITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REGULATORY MECHANISM; RESPIRATORY CHAIN; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION; STATIC ELECTRICITY; STEADY STATE;

EID: 84880912148     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2013.790873     Document Type: Review

References (277)

1. Abe J, Takahashi M, Ishida M, et al. (1997). c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem 272:20389-94. (Pubitemid 27355589)
2. Abid MR, Kachra Z, Spokes KC, Aird WC. (2000). NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett 486:252-6.
3. Abid MR, Spokes KC, Shih SC, Aird WC. (2007). NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem 282:35373-85. (Pubitemid 350232487)
4. Akhand AA, Pu M, Senga T, et al. (1999). Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J Biol Chem 274:25821-6.
5. Anastasiou D, Poulogiannis G, Asara JM, et al. (2011). Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334:1278-83.
6. Anderson TA, Sauer RT. (2003). Role of an N(cap) residue in determining the stability and operator-binding affinity of Arc repressor. Biophys Chem 100:341-50. (Pubitemid 36338051)
7. Andrae J, Gallini R, Betsholtz C. (2008). Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276-312. (Pubitemid 351717519)
8. Arbiser JL, Petros J, Klafter R, et al. (2002). Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99: 715-20. (Pubitemid 34106576)
9. Aslan M, Ozben T. (2003). Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid Redox Signal 5:781-8. (Pubitemid 37462061)
10. Avruch J. (1998). Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182:31-48. (Pubitemid 28181646)
11. Babior BM. (2000). The NADPH oxidase of endothelial cells. IUBMB Life 50:267-9. (Pubitemid 32289084)
12. Bae YS, Kang SW, Seo MS, et al. (1997). Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272:217-21. (Pubitemid 27021147)
13. Bae YS, Sung JY, Kim OS, et al. (2000). Platelet-derived growth factorinduced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275:10527-31. (Pubitemid 30202116)
14. Banerjee R, ed. (2008). Redox biochemistry. Hoboken (NJ): John Wiley & Sons.
15. Barnham KJ, Masters CL, Bush AI. (2004). Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205-14.
16. Benitez LV, Allison WS. (1974). The inactivation of the acyl phosphatase activity catalyzed by the sulfenic acid form of glyceraldehyde 3-phosphate dehydrogenase by dimedone and olefins. J Biol Chem 249:6234-43.
17. Bienert GP, Moller AL, Kristiansen KA, et al. (2007). Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem 282:1183-92. (Pubitemid 47076557)
18. Bienert GP, Schjoerring JK, Jahn TP. (2006). Membrane transport of hydrogen peroxide. Biochim Biophys Acta 1758:994-1003. (Pubitemid 44373854)
19. Blume-Jensen P, Hunter T. (2001). Oncogenic kinase signalling. Nature 411:355-65. (Pubitemid 32467045)
20. Boivin B, Zhang S, Arbiser JL, et al. (2008). A modified cysteinyllabeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells. Proc Natl Acad Sci USA 105:9959-64.
21. Buhrow SA, Cohen S, Staros JV. (1982). Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells. J Biol Chem 257:4019-22.
22. Cantley LC, Neel BG. (1999). New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-5. (Pubitemid 29190320)
23. Carpenter G, King Jr L, Cohen S. (1978). Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 276:409-10. (Pubitemid 9096475)
24. Carvalho-Filho MA, Ueno M, Hirabara SM, et al. (2005). S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54: 959-67. (Pubitemid 40446309)
25. 2. J Biol Chem 273:32554-60. (Pubitemid 28557633)
26. Chan TO, Rittenhouse SE, Tsichlis PN. (1999). AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014. (Pubitemid 29449213)
27. Chen K, Kirber MT, Xiao H, et al. (2008). Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181: 1129-39. (Pubitemid 351915488)
28. Chen Q, Olashaw N, Wu J. (1995). Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 270: 28499-502.
29. Chen K, Thomas SR, Albano A, et al. (2004). Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J Biol Chem 279:35079-86. (Pubitemid 39318144)
30. Chen K, Vita JA, Berk BC, Keaney Jr JF. (2001a). c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:16045-50.
31. Chen WS, Xu PZ, Gottlob K, et al. (2001b). Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15:2203-8. (Pubitemid 32843832)
32. Cheng G, Cao Z, Xu X, et al. (2001). Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269:131-40. (Pubitemid 32488913)
33. Chiarugi P, Buricchi F. (2007). Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid Redox Signal 9:1-24. (Pubitemid 44910992)
34. Chiarugi P, Cirri P, Raugei G, et al. (1995). PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase. FEBS Lett 372:49-53.
35. Chiarugi P, Cirri P, Taddei ML, et al. (2002). New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases. J Cell Sci 115:2219-32. (Pubitemid 34746387)
36. Chiarugi P, Fiaschi T, Taddei ML, et al. (2001). Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276:33478-87.
37. Cho H, Mu J, Kim JK, et al. (2001a). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728-31. (Pubitemid 32506248)
38. Cho H, Thorvaldsen JL, Chu Q, et al. (2001b). Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349-52.
39. Choi MH, Lee IK, Kim GW, et al. (2005). Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435: 347-53. (Pubitemid 40745544)
40. 2 in rat heart endothelial cells. Free Radic Biol Med 25:891-7. (Pubitemid 28538554)
41. Clark S, Konstantopoulos N. (1993). Sulphydryl agents modulate insulinand epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors. Biochem J 292:217-23. (Pubitemid 23158984)
42. Cohen S. (2008). Origins of growth factors: NGF and EGF. J Biol Chem 283:33793-7.
43. Cohen S, Carpenter G, King Jr L. (1980). Epidermal growth factorreceptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem 255:4834-42.
44. Colavitti R, Pani G, Bedogni B, et al. (2002). Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277:3101-8. (Pubitemid 34953170)
45. Cross DA, Alessi DR, Cohen P, et al. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-9. (Pubitemid 26004411)
46. Cross JV, Templeton DJ. (2004). Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J 381:675-83. (Pubitemid 39120476)
47. Cunnick JM, Dorsey JF, Standley T, et al. (1998). Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J Biol Chem 273:14468-75. (Pubitemid 28319168)
48. D'Autreaux B, Toledano MB. (2007). ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813-24. (Pubitemid 47462134)
49. De Deken X, Wang D, Many MC, et al. (2000). Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275:23227-33. (Pubitemid 30646220)
50. Denu JM, Tanner KG. (1998). Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37:5633-42. (Pubitemid 28241948)
51. Depuydt M, Messens J, Collet JF. (2011). How proteins form disulfide bonds. Antioxid Redox Signal 15:49-66.
52. Devary Y, Gottlieb RA, Lau LF, Karin M. (1991). Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11:2804-11. (Pubitemid 21895661)
53. DeYulia Jr GJ, Carcamo JM. (2005). EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFRassociated protein tyrosine phosphatases. Biochem Biophys Res Commun 334:38-42. (Pubitemid 40978504)
54. DeYulia Jr GJ, Carcamo JM, Borquez-Ojeda O, et al. (2005). Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling. Proc Natl Acad Sci USA 102: 5044-9.
55. Diao Y, Liu W, Wong CC, et al. (2010). Oxidation-induced intramolecular disulfide bond inactivates mitogen-activated protein kinase kinase 6 by inhibiting ATP binding. Proc Natl Acad Sci USA 107:20974-9.
56. Dickinson BC, Chang CJ. (2011). Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol 7: 504-11.
57. Dolfi F, Garcia-Guzman M, Ojaniemi M, et al. (1998). The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway. Proc Natl Acad Sci USA 95:15394-9. (Pubitemid 29018709)
58. Elchebly M, Payette P, Michaliszyn E, et al. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-8.
59. Engelman JA, Luo J, Cantley LC. (2006). The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-19. (Pubitemid 44100518)
60. Esposito F, Chirico G, Montesano Gesualdi N, et al. (2003). Protein kinase B activation by reactive oxygen species is independent of tyrosine kinase receptor phosphorylation and requires SRC activity. J Biol Chem 278:20828-34. (Pubitemid 36806388)
61. Ferrara N, Gerber HP, Lecouter J. (2003). The biology of VEGF and its receptors. Nat Med 9:669-76. (Pubitemid 36749215)
62. Finkel T. (2011). Signal transduction by reactive oxygen species. J Cell Biol 194:7-15.
63. Finkel T. (2012). From sulfenylation to sulfhydration: what a thiolate needs to tolerate. Sci Signal 5:pe10.
64. Finkel T, Serrano M, Blasco MA. (2007). The common biology of cancer and ageing. Nature 448:767-74. (Pubitemid 47266334)
65. Flint AJ, Tiganis T, Barford D, Tonks NK. (1997). Development of "substrate-trapping" mutantsto identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 94:1680-5.
66. Franke TF, Kaplan DR, Cantley LC, Toker A. (1997). Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665-8. (Pubitemid 27061333)
67. Fridovich I. (1995). Superoxide radical and superoxide dismutases. Annu Rev Biochem 64:97-112.
68. Gamou S, Shimizu N. (1995). Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor. FEBS Lett 357:161-4.
69. Gardner PR, Raineri I, Epstein LB, White CW. (1995). Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem 270:13399-405.
70. Gianni D, Bohl B, Courtneidge SA, Bokoch GM. (2008). The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. Mol Biol Cell 19:2984-94.
71. Giannoni E, Buricchi F, Grimaldi G, et al. (2008). Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ 15:867-78. (Pubitemid 351524429)
72. Giannoni E, Buricchi F, Raugei G, et al. (2005). Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 25:6391-403. (Pubitemid 41023216)
73. Giannoni E, Taddei ML, Chiarugi P. (2010). Src redox regulation: again in the front line. Free Radic Biol Med 49:516-27.
74. Giorgio M, Migliaccio E, Orsini F, et al. (2005). Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122:221-33. (Pubitemid 41032986)
75. Giorgio M, Trinei M, Migliaccio E, Pelicci PG. (2007). Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8:722-8. (Pubitemid 47312827)
76. Go YM, Jones DP. (2013). Thiol/disulfide redox states in signaling and sensing. Crit Rev Biochem Mol Biol 48:173-81.
77. 2 redox stress. Am J Respir Cell Mol Biol 19:786-98. (Pubitemid 128353678)
78. Gonzalez E, Mcgraw TE. (2009a). The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8:2502-8.
79. Gonzalez E, Mcgraw TE. (2009b). Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling. Proc Natl Acad Sci USA 106:7004-9.
80. 2. Am J Physiol Heart Circ Physiol 291:H1395-401. (Pubitemid 44343686)
81. Gorlach A, Brandes RP, Nguyen K, et al. (2000). A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32. (Pubitemid 30456931)
82. Grazia Lampugnani M, Zanetti A, Corada M, et al. (2003). Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 161:793-804. (Pubitemid 36648762)
83. Guo Z, Deshpande R, Paull TT. (2010a). ATM activation in the presence of oxidative stress. Cell Cycle 9:4805-11.
84. Guo Z, Kozlov S, Lavin MF, et al. (2010b). ATM activation by oxidative stress. Science 330:517-21.
85. 2. Role in cell survival following oxidant injury. J Biol Chem 271:4138-42.
86. Haj FG, Markova B, Klaman LD, et al. (2003). Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278:739-44. (Pubitemid 36790744)
87. Haj FG, Verveer PJ, Squire A, et al. (2002). Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295:1708-11. (Pubitemid 34202905)
88. Hall A, Karplus PA, Poole LB. (2009). Typical 2-Cys peroxiredoxins- structures, mechanisms and functions. FEBS J 276:2469-77.
89. Halvey PJ, Watson WH, Hansen JM, et al. (2005). Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem J 386:215-19. (Pubitemid 40343778)
90. Handy DE, Lubos E, Yang Y, et al. (2009). Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J Biol Chem 284:11913-21.
91. Haque A, Andersen JN, Salmeen A, et al. (2011). Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity. Cell 147:185-98.
92. Heeneman S, Haendeler J, Saito Y, et al. (2000). Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J Biol Chem 275:15926-32. (Pubitemid 30366895)
93. Heldin CH, Westermark B. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-316. (Pubitemid 29473317)
94. Herbst RS. (2004). Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59:21-6. (Pubitemid 38610223)
95. Hess DT, Stamler JS. (2012). Regulation by S-nitrosylation of protein post-translational modification. J Biol Chem 287:4411-18.
96. Houstis N, Rosen ED, Lander ES. (2006). Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944-8.
97. Hsu JL, Hsieh Y, Tu C, et al. (1996). Catalytic properties of human manganese superoxide dismutase. J Biol Chem 271:17687-91. (Pubitemid 26250738)
98. Huang X, Begley M, Morgenstern KA, et al. (2003). Crystal structure of an inactive Akt2 kinase domain. Structure 11:21-30. (Pubitemid 36071494)
99. Hubbard SR, Till JH. (2000). Protein tyrosine kinase structure and function. Annu Rev Biochem 69:373-98.
100. Ichijo H, Nishida E, Irie K, et al. (1997). Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90-4. (Pubitemid 27020316)
101. Ikeda S, Ushio-Fukai M, Zuo L, et al. (2005a). Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 96:467-75. (Pubitemid 40354541)
102. Ikeda S, Yamaoka-Tojo M, Hilenski L, et al. (2005b). IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol 25:2295-300. (Pubitemid 41552645)
103. Jacob C, Battaglia E, Burkholz T, et al. (2012). Control of oxidative posttranslational cysteine modifications: from intricate chemistry to widespread biological and medical applications. Chem Res Toxicol 25:588-604.
104. Jacob C, Winyard PG, eds. (2009). Redox signaling and regulation in biology and medicine. Weinheim: Wiley-VCH.
105. Jaspers I, Zhang W, Fraser A, et al. (2001). Hydrogen peroxide has opposing effects on IKK activity and Ikappa Balpha breakdown in airway epithelial cells. Am J Respir Cell Mol Biol 24:769-77. (Pubitemid 32554616)
106. Joneson T, Bar-Sagi D. (1998). A Rac1 effector site controlling mitogenesis through superoxide production. J Biol Chem 273:17991-4. (Pubitemid 28334708)
107. 2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci USA 105: 7147-52. (Pubitemid 351754446)
108. Kageyama K, Ihara Y, Goto S, et al. (2002). Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J Biol Chem 277:19255-64. (Pubitemid 34967429)
109. Kamata H, Honda S, Maeda S, et al. (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649-61. (Pubitemid 40343077)
110. Kamata H, Manabe T, Oka S, et al. (2002). Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett 519:231-7. (Pubitemid 34522025)
111. Kanda M, Ihara Y, Murata H, et al. (2006). Glutaredoxin modulates platelet-derived growth factor-dependent cell signaling by regulating the redox status of low molecular weight protein-tyrosine phosphatase. J Biol Chem 281:28518-28. (Pubitemid 44506994)
112. Kang SW, Chae HZ, Seo MS, et al. (1998). Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273: 6297-302. (Pubitemid 28144719)
113. Kang DH, Lee DJ, Lee KW, et al. (2011). Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol Cell 44:545-58.
114. Kapahi P, Takahashi T, Natoli G, et al. (2000). Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem 275:36062-6.
115. Kaplan N, Urao N, Furuta E, et al. (2011). Localized cysteine sulfenic acid formation by vascular endothelial growth factor: role in endothelial cell migration and angiogenesis. Free Radic Res 45:1124-35.
116. Kemble DJ, Sun G. (2009). Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proc Natl Acad Sci USA 106:5070-5.
117. Kido Y, Nakae J, Accili D. (2001). Clinical review 125: The insulin receptor and its cellular targets. J Clin Endocrinol Metab 86:972-9. (Pubitemid 32322967)
118. Klaman LD, Boss O, Peroni OD, et al. (2000). Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479-89. (Pubitemid 30482885)
119. Klomsiri C, Karplus PA, Poole LB. (2011). Cysteine-based redox switches in enzymes. Antioxid Redox Signal 14:1065-77.
120. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. (1996). Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372-8. (Pubitemid 26408588)
121. Korn SH, Wouters EF, Vos N, Janssen-Heininger YM. (2001). Cytokineinduced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem 276:35693-700.
122. Krasnowska EK, Pittaluga E, Brunati AM, et al. (2008). N-acetyl-lcysteine fosters inactivation and transfer to endolysosomes of c-Src. Free Radic Biol Med 45:1566-72.
123. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89: 1006-13.
124. 2 generation in 3T3 L1-cells. Biochem J 307:549-56.
125. 2 generation in human adipocyte plasma membranes is mediated by Galphai2. J Biol Chem 272: 10135-43. (Pubitemid 27171690)
126. Kroviarski Y, Debbabi M, Bachoual R, et al. (2010). Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J 24:2077-92.
127. Kuroki M, Voest EE, Amano S, et al. (1996). Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98:1667-75. (Pubitemid 26327878)
128. Kwarcinski FE, Fox CC, Steffey ME, Soellner MB. (2012). Irreversible inhibitors of c-Src kinase that target a nonconserved cysteine. ACS Chem Biol 7:1910-17.
129. Kwon J, Lee SR, Yang KS, et al. (2004). Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 101:16419-24. (Pubitemid 39557728)
130. Labrecque L, Royal I, Surprenant DS, et al. (2003). Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell 14:334-47. (Pubitemid 36106041)
131. Lam YW, Yuan Y, Isaac J, et al. (2010). Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells. PLoS One 5:e9075.
132. Lambeth JD. (2004). NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-9. (Pubitemid 38339084)
133. Lander HM, Milbank AJ, Tauras JM, et al. (1996). Redox regulation of cell signalling. Nature 381:380-1. (Pubitemid 126515840)
134. Lassegue B, Sorescu D, Szocs K, et al. (2001). Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-94. (Pubitemid 32441466)
135. Lee JW, Kim JE, Park EJ, et al. (2004). Two conserved cysteine residues are critical for the enzymic function of the human platelet-derived growth factor receptor-beta: evidence for different roles of Cys-822 and Cys-940 in the kinase activity. Biochem J 382: 631-9.
136. Lee SR, Kwon KS, Kim SR, Rhee SG. (1998). Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273:15366-72. (Pubitemid 28298140)
137. 2. J Biol Chem 277:20336-42. (Pubitemid 34967328)
138. Leonard SE, Garcia FJ, Goodsell DS, Carroll KS. (2011). Redox-based probes for protein tyrosine phosphatases. Angew Chem Int Ed Engl 50:4423-7.
139. Leonard SE, Reddie KG, Carroll KS. (2009). Mining the thiol proteome for sulfenic acid modifications reveals new targets for oxidation in cells. ACS Chem Biol 4:783-99.
140. Leonberg AK, Chai YC. (2007). The functional role of cysteine residues for c-Abl kinase activity. Mol Cell Biochem 304:207-12. (Pubitemid 47456867)
141. Leslie NR. (2006). The redox regulation of PI 3-kinase-dependent signaling. Antioxid Redox Signal 8:1765-74. (Pubitemid 44726350)
142. Leslie NR, Bennett D, Lindsay YE, et al. (2003). Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22:5501-10. (Pubitemid 37279959)
143. Levinson NM, Seeliger MA, Cole PA, Kuriyan J. (2008). Structural basis for the recognition of c-Src by its inactivator Csk. Cell 134: 124-34. (Pubitemid 351916707)
144. Li W, Schlessinger J. (1991). Platelet-derived growth factor (PDGF)-induced disulfide-linked dimerization of PDGF receptor in living cells. Mol Cell Biol 11:3756-61. (Pubitemid 21895763)
145. Li Q, Zhang Y, Marden JJ, et al. (2008). Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury. Biochem J 411:531-41. (Pubitemid 351600738)
146. Lin Y, Berg AH, Iyengar P, et al. (2005). The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 280:4617-26. (Pubitemid 40288630)
147. Liu H, Nishitoh H, Ichijo H, Kyriakis JM. (2000). Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptorassociated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 20:2198-208. (Pubitemid 30123835)
148. Liu Q, Sabnis Y, Zhao Z, et al. (2013). Developing irreversible inhibitors of the protein kinase cysteinome. Chem Biol 20:146-59.
149. Lo YY, Cruz TF. (1995). Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270:11727-30.
150. Lo YY, Wong JM, Cruz TF. (1996). Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 271: 15703-7. (Pubitemid 26225348)
151. Lohse DL, Denu JM, Santoro N, Dixon JE. (1997). Roles of aspartic acid-181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphatase PTP1. Biochemistry 36: 4568-75. (Pubitemid 27180305)
152. Lowell BB, Shulman GI. (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307:384-7. (Pubitemid 40139974)
153. Lu Y, Yu Q, Liu JH, et al. (2003). Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem 278:40057-66. (Pubitemid 37248572)
154. Lu Z, Xu S. (2006). ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 58:621-31. (Pubitemid 44691463)
155. Ma YC, Huang XY. (2002). Novel regulation and function of Src tyrosine kinase. Cell Mol Life Sci 59:456-62.
156. Macias A, Azavedo E, Hagerstrom T, et al. (1987). Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res 7:459-64. (Pubitemid 17151935)
157. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24: 1844-54. (Pubitemid 38248927)
158. Mahadev K, Wu X, Zilbering A, et al. (2001a). Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276:48662-9.
159. Mahadev K, Zilbering A, Zhu L, Goldstein BJ. (2001b). Insulinstimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276:21938-42.
160. Maller C, Schroder E, Eaton P. (2011). Glyceraldehyde 3-phosphate dehydrogenase is unlikely to mediate hydrogen peroxide signaling: studies with a novel anti-dimedone sulfenic acid antibody. Antioxid Redox Signal 14:49-60.
161. Mamathambika BS, Bardwell JC. (2008). Disulfide-linked protein folding pathways. Annu Rev Cell Dev Biol 24:211-35.
162. Manning BD, Cantley LC. (2007). AKT/PKB signaling: navigating downstream. Cell 129:1261-74. (Pubitemid 46962095)
163. Manning G, Whyte DB, Martinez R, et al. (2002). The protein kinase complement of the human genome. Science 298:1912-34. (Pubitemid 35425239)
164. Matsuzawa A, Ichijo H. (2005). Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal 7:472-81. (Pubitemid 40279816)
165. May JM, de Haen C. (1979a). The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem 254:9017-21. (Pubitemid 10239442)
166. May JM, de Haen C. (1979b). Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J Biol Chem 254: 2214-20. (Pubitemid 9160038)
167. Mccord JM, Fridovich I. (1969). Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-55.
168. McCubrey JA, Lahair MM, Franklin RA. (2006). Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8:1775-89. (Pubitemid 44726351)
169. Mebratu Y, Tesfaigzi Y. (2009). How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8:1168-75.
170. 2-induced phosphorylation of ERK1/2 and PKBrequires tyrosine kinase activity of insulin receptor and c-Src. Antioxid Redox Signal 7:1014-20. (Pubitemid 40967152)
171. Meng TC, Fukada T, Tonks NK. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-99. (Pubitemid 34195563)
172. Migliaccio E, Giorgio M, Mele S, et al. (1999). The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402:309-13. (Pubitemid 129516269)
173. Miller EW, Dickinson BC, Chang CJ. (2010). Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc Natl Acad Sci USA 107:15681-6.
174. Miller EW, Tulyathan O, Isacoff EY, Chang CJ. (2007). Molecular imaging of hydrogen peroxide produced for cell signaling. Nat Chem Biol 3:263-7. (Pubitemid 46625830)
175. Mills JE, Whitford PC, Shaffer J, et al. (2007). A novel disulfide bond in the SH2 Domain of the C-terminal Src kinase controls catalytic activity. J Mol Biol 365:1460-8. (Pubitemid 46048832)
176. Mukherjee SP, Lane RH, Lynn WS. (1978). Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochem Pharmacol 27: 2589-94. (Pubitemid 9072561)
177. Murata H, Ihara Y, Nakamura H, et al. (2003). Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278:50226-33. (Pubitemid 37548863)
178. Murillo-Carretero M, Torroglosa A, Castro C, et al. (2009). S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity. Free Radic Biol Med 46:471-9.
179. Nadeau PJ, Charette SJ, Landry J. (2009). REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis. Mol Biol Cell 20:3628-37.
180. Nadeau PJ, Charette SJ, Toledano MB, Landry J. (2007). Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. Mol Biol Cell 18:3903-13. (Pubitemid 47519483)
181. Nakamura Y, Patrushev N, Inomata H, et al. (2008). Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res 102: 1182-91.
182. Nakashima I, Kato M, Akhand AA, et al. (2002). Redox-linked signal transduction pathways for protein tyrosine kinase activation. Antioxid Redox Signal 4:517-31. (Pubitemid 34753392)
183. Nakashima N, Sharma PM, Imamura T, et al. (2000). The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem 275:12889-95. (Pubitemid 30241444)
184. Nose K, Shibanuma M, Kikuchi K, et al. (1991). Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur J Biochem 201:99-106.
185. Oh H, Jung HY, Kim J, Bae YS. (2010). Phosphorylation of serine282 in NADPH oxidase activator 1 by Erk desensitizes EGF-induced ROS generation. Biochem Biophys Res Commun 394:691-6.
186. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. (2006). VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 7:359-71.
187. 2 promotes VEGF signaling in caveolae/lipid rafts and postischemic angiogenesis in mice. PLoS One 5:e10189.
188. Pantano C, Reynaert NL, Van Der Vliet A, Janssen-Heininger YM. (2006). Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 8:1791-806. (Pubitemid 44726352)
189. Park HS, Huh SH, Kim MS, et al. (2000). Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc Natl Acad Sci USA 97:14382-7.
190. 2. Mol Cell Biol 24: 4384-94. (Pubitemid 41071008)
191. Park HS, Yu JW, Cho JH, et al. (2004b). Inhibition of apoptosis signalregulating kinase 1 by nitric oxide through a thiol redox mechanism. J Biol Chem 279:7584-90.
192. Parsonage D, Karplus PA, Poole LB. (2008). Substrate specificity and redox potential of AhpC, a bacterial peroxiredoxin. Proc Natl Acad Sci USA 105:8209-14. (Pubitemid 351904736)
193. Paulsen CE, Carroll KS. (2010). Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol 5:47-62.
194. Paulsen CE, Truong TH, Garcia FJ, et al. (2012). Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat Chem Biol 8:57-64.
195. Penel S, Hughes E, Doig AJ. (1999). Side-chain structures in the first turn of the alpha-helix. J Mol Biol 287:127-43. (Pubitemid 29134802)
196. Peskin AV, Low FM, Paton LN, et al. (2007). The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents. J Biol Chem 282:11885-92. (Pubitemid 47100684)
197. Poole LB, Klomsiri C, Knaggs SA, et al. (2007). Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins. Bioconjug Chem 18:2004-17. (Pubitemid 350220002)
198. Poole LB, Zeng BB, Knaggs SA, et al. (2005). Synthesis of chemical probes to map sulfenic acid modifications on proteins. Bioconjug Chem 16:1624-8. (Pubitemid 41681531)
199. Raha S, Robinson BH. (2000). Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 25:502-8.
200. Rahman MA, Senga T, Ito S, et al. (2010). S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion. J Biol Chem 285:3806-14.
201. Reddie KG, Carroll KS. (2008). Expanding the functional diversity of proteins through cysteine oxidation. Curr Opin Chem Biol 12: 746-54.
202. Reddie KG, Seo YH, Muse III, et al. (2008). A chemical approach for detecting sulfenic acid-modified proteins in living cells. Mol Biosyst 4: 521-31. (Pubitemid 351706295)
203. Reynaert NL, Ckless K, Korn SH, et al. (2004). Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci USA 101:8945-50. (Pubitemid 38781591)
204. Reynaert NL, Van Der Vliet A, Guala AS, et al. (2006). Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 103:13086-91. (Pubitemid 44338920)
205. Reynolds AR, Tischer C, Verveer PJ, et al. (2003). EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat Cell Biol 5:447-53. (Pubitemid 36592268)
206. 2, a necessary evil for cell signaling. Science 312:1882-3. (Pubitemid 43993698)
207. Roberts PJ, Der CJ. (2007). Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene 26:3291-310. (Pubitemid 46763022)
208. Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. (2002). A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew Chem Int Ed Engl 41:2596-9. (Pubitemid 34803480)
209. Rudich A, Tirosh A, Potashnik R, et al. (1998). Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47:1562-9. (Pubitemid 28445343)
210. Saito Y, Berk BC. (2001). Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33:3-7. (Pubitemid 32127779)
211. Saito S, Frank GD, Mifune M, et al. (2002). Ligand-independent transactivation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src. J Biol Chem 277:44695-700. (Pubitemid 36159059)
212. Saitoh M, Nishitoh H, Fujii M, et al. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596-606. (Pubitemid 28221195)
213. Salsbury Jr. FR, Knutson ST, Poole LB, Fetrow JS. (2008). Functional site profiling and electrostatic analysis of cysteines modifiable to cysteine sulfenic acid. Protein Sci 17:299-312. (Pubitemid 351171842)
214. Saltiel AR, Kahn CR. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806. (Pubitemid 34000783)
215. Saxon E, Bertozzi CR. (2000). Cell surface engineering by a modified Staudinger reaction. Science 287:2007-10. (Pubitemid 30158675)
216. Schlessinger J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103:211-25.
217. Schlessinger J. (2002). Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110:669-72. (Pubitemid 35283957)
218. Schmid E, El Benna J, Galter D, et al. (1998). Redox priming of the insulin receptor beta-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J 12:863-70. (Pubitemid 28294676)
219. Schmitt TL, Hotz-Wagenblatt A, Klein H, Droge W. (2005). Interdependent regulation of insulin receptor kinase activity by ADP and hydrogen peroxide. J Biol Chem 280:3795-801. (Pubitemid 40223848)
220. Seo JH, Ahn Y, Lee SR, et al. (2005). The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol Biol Cell 16:348-57. (Pubitemid 40024316)
221. Seo YH, Carroll KS. (2009). Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies. Proc Natl Acad Sci USA 106:16163-8.
222. Seo YH, Carroll KS. (2011). Quantification of protein sulfenic acid modifications using isotope-coded dimedone and iododimedone. Angew Chem Int Ed Engl 50:1342-5.
223. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J 336:241-6. (Pubitemid 28532583)
224. Singh J, Dobrusin EM, Fry DW, et al. (1997). Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases. J Med Chem 40:1130-5. (Pubitemid 27149266)
225. Singh J, Petter RC, Baillie TA, Whitty A. (2011). The resurgence of covalent drugs. Nat Rev Drug Discov 10:307-17.
226. Singh J, Petter RC, Kluge AF. (2010). Targeted covalent drugs of the kinase family. Curr Opin Chem Biol 14:475-80.
227. Sondhi D, Xu W, Songyang Z, et al. (1998). Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism. Biochemistry 37:165-72. (Pubitemid 28049118)
228. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. (2002). Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277: 44784-90. (Pubitemid 36159072)
229. Stambolic V, Suzuki A, De La Pompa JL, et al. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39. (Pubitemid 28458022)
230. Stockler-Ipsiroglu S. (1997). Creatine deficiency syndromes: a new perspective on metabolic disorders and a diagnostic challenge. J Pediatr 131:510-11. (Pubitemid 28006918)
231. Stokoe D, Stephens LR, Copeland T, et al. (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-70. (Pubitemid 27369005)
232. Stone JR, Yang S. (2006). Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8:243-70. (Pubitemid 43741296)
233. Suh YA, Arnold RS, Lassegue B, et al. (1999). Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82.
234. Sun G, Kemble DJ. (2009). To C or not to C: direct and indirect redox regulation of Src protein tyrosine kinase. Cell Cycle 8:2353-5.
235. 2 for platelet-derived growth factor signal transduction. Science 270:296-9.
236. Sundaresan M, Yu ZX, Ferrans VJ, et al. (1996). Regulation of reactiveoxygen-species generation in fibroblasts by Rac1. Biochem J 318: 379-82. (Pubitemid 26305933)
237. Switzer CH, Glynn SA, Cheng RY, et al. (2012). S-Nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Mol Cancer Res 10:1203-15.
238. Tang H, Hao Q, Rutherford SA, et al. (2005). Inactivation of SRC family tyrosine kinases by reactive oxygen species in vivo. J Biol Chem 280: 23918-25. (Pubitemid 40884880)
239. Taylor SS, Knighton DR, Zheng J, et al. (1992). Structural framework for the protein kinase family. Annu Rev Cell Biol 8:429-62. (Pubitemid 23001004)
240. Templeton DJ, Aye MS, Rady J, et al. (2010). Purification of reversibly oxidized proteins (PROP) reveals a redox switch controlling p38 MAP kinase activity. PLoS One 5:e15012.
241. Thannickal VJ, Day RM, Klinz SG, et al. (2000). Ras-dependent and-independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta1. FASEB J 14:1741-8.
242. Thomas SM, Brugge JS. (1997). Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513-609. (Pubitemid 28034534)
243. Truong TH, Carroll KS. (2012). Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation. Biochemistry 51: 9954-65.
244. Truong TH, Garcia FJ, Seo YH, Carroll KS. (2011). Isotope-coded chemical reporter and acid-cleavable affinity reagents for monitoring protein sulfenic acids. Bioorg Med Chem Lett 21:5015-20.
245. Turner N, Grose R. (2010). Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10:116-29.
246. Ueki K, Yamamoto-Honda R, Kaburagi Y, et al. (1998). Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273:5315-22. (Pubitemid 28108698)
247. Ushio-Fukai M. (2006). Localizing NADPH oxidase-derived ROS. Sci STKE 2006:re8.
248. Ushio-Fukai M. (2007). VEGF signaling through NADPH oxidasederived ROS. Antioxid Redox Signal 9:731-9. (Pubitemid 46799105)
249. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. (1998). p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-9. (Pubitemid 28272796)
250. Ushio-Fukai M, Alexander RW, Akers M, et al. (1999). Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 274: 22699-704.
251. Ushio-Fukai M, Griendling KK, Becker PL, et al. (2001). Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21:489-95. (Pubitemid 32323378)
252. Ushio-Fukai M, Tang Y, Fukai T, et al. (2002). Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factorinduced signaling and angiogenesis. Circ Res 91:1160-7. (Pubitemid 36076365)
253. Van der Kaay J, Beck M, Gray A, Downes CP. (1999). Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses. J Biol Chem 274:35963-8. (Pubitemid 129512906)
254. Veal EA, Findlay VJ, Day AM, et al. (2004). A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stressactivated MAP kinase. Mol Cell 15:129-39. (Pubitemid 38850225)
255. Vivanco I, Rohle D, Versele M, et al. (2010). The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation. Proc Natl Acad Sci USA 107:6459-64.
256. Wagner EF, Nebreda AR. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-49.
257. Wang X, Martindale JL, Liu Y, Holbrook NJ. (1998). The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333:291-300. (Pubitemid 28379529)
258. Wang X, Mccullough KD, Franke TF, Holbrook NJ. (2000). Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem 275:14624-31. (Pubitemid 30339753)
259. Wani R, Qian J, Yin L, et al. (2011). Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species. Proc Natl Acad Sci USA 108:10550-5.
260. Wilden PA, Pessin JE. (1987). Differential sensitivity of the insulinreceptor kinase to thiol and oxidizing agents in the absence and presence of insulin. Biochem J 245:325-31. (Pubitemid 17097610)
261. Winterbourn CC. (2008). Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4:278-86. (Pubitemid 351550893)
262. Winterbourn CC, Metodiewa D. (1999). Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 27:322-8. (Pubitemid 29395424)
263. Woltjer RL, Staros JV. (1997). Effects of sulfhydryl modification reagents on the kinase activity of the epidermal growth factor receptor. Biochemistry 36:9911-16. (Pubitemid 27364703)
264. Woo HA, Yim SH, Shin DH, et al. (2010). Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 140:517-28.
265. Wortzel I, Seger R. (2011). The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer 2:195-209.
266. Xu W, Harrison SC, Eck MJ. (1997). Three-dimensional structure of the tyrosine kinase c-Src. Nature 385:595-602. (Pubitemid 27087566)
267. Yamaoka-Tojo M, Tojo T, Kim HW, et al. (2006). IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. Arterioscler Thromb Vasc Biol 26:1991-7. (Pubitemid 44253779)
268. Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L, et al. (2004). IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ Res 95:276-83. (Pubitemid 39056288)
269. Yarden Y, Sliwkowski MX. (2001). Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-37. (Pubitemid 33674041)
270. Yasukawa T, Tokunaga E, Ota H, et al. (2005). S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280:7511-18. (Pubitemid 40349643)
271. Yeatman TJ. (2004). A renaissance for SRC. Nat Rev Cancer 4:470-80. (Pubitemid 38745532)
272. Yellaturu CR, Bhanoori M, Neeli I, Rao GN. (2002). N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem 277: 40148-55. (Pubitemid 35191007)
273. Yoo SK, Starnes TW, Deng Q, Huttenlocher, A. (2011). Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 480: 109-12.
274. Yoshizumi M, Abe J, Haendeler J, et al. (2000). Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 275:11706-12. (Pubitemid 30237733)
275. Youngren JF. (2007). Regulation of insulin receptor function. Cell Mol Life Sci 64:873-91. (Pubitemid 46597750)
276. Zhang T, Inesta-Vaquera F, Niepel M, et al. (2012). Discovery of potent and selective covalent inhibitors of JNK. Chem Biol 19:140-54.
277. Zhang ZY, Dixon JE. (1993). Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry 32:9340-5. (Pubitemid 23292052)